Ridazolol is a pharmaceutical drug acting as a beta adrenergic receptor antagonist.

It was investigated in the 1980 and 90s for its effects on coronary heart disease and essential hypertension (high blood pressure).

[1][2] It is not known to be marketed anywhere in the world.

This drug article relating to the cardiovascular system is a stub.

You can help Wikipedia by expanding it.